| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215809 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 32 Pages |
Abstract
TSEB therapy is an efficacious treatment modality in the treatment of several forms of cutaneous T-cell lymphoma. There is a nonsignificant trend to higher and longer clinical benefit for MF and SS patients receiving conventional dose. Low-dose TSEB regimens are well tolerated and achieve short-term palliation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Khaled Elsayad, Jan MD, Christos PhD, Sergiu MD, Gabriele MD, Uwe PhD, Normann MD, PhD, Carsten MD, Rudolf MD, PhD, Cord MD, PhD, Hans Theodor MD, PhD,